Publications
5891 Results
- Journal / Conference
- San Antonio Breast Cancer Symposium, abst. 112, poster discussion presentation
- Year
- 2009
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8814
Prediction of 10-year chemotherapy benefit and breast cancer-specific survival by the 21-gene recurrence score (RS) assay in node-positive, ER-positive breast cancer - An update of SWOG-8814 (INT0100)
- Journal / Conference
- Clinical Lung Cancer 10(6):395-404
- Year
- 2009
- Research Committee(s)
- Lung
- PMC
- n/a (review)
- Study Number(s)
- S0023, S0342, S0720, S0819, SWOG-9038
Cooperative group research efforts in thoracic malignancies 2009: a review from the 10th Annual International Lung Cancer Congress [PMID19900856]
- Journal / Conference
- Nature Genetics 41:843-848
- Year
- 2009
- Research Committee(s)
- Leukemia
- Study Number(s)
- S9706
Lin28 enhances tumorigenesis and is associated with advanced human malignancies [PMC2757943; PMID19483683]
- Journal / Conference
- Frontiers in Cancer Prevention Research, AACR, abstract #B26, p. 116 (poster presentation)
- Year
- 2009
- Research Committee(s)
- Cancer Control, Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000, SWOG-9217
Cancer prevention clinical trials: assessing for disparities in recruitment in Hawaii
- Journal / Conference
- Journal of Thoracic Oncology 4(9):suppl 1, abst. D5.7, S396, 2009 (IASLC 13th World Conf on Lung Cancer, oral pres);
- Year
- 2009
- Research Committee(s)
- Lung
- Study Number(s)
- S0124
Final pooled comparative outcomes analysis of JCOG 9511 and SWOG 0124, phase III trials of cisplatin + irinotecan vs. cisplatin + etoposide in extensive stage small cell lung cancer
- Journal / Conference
- Journal of Thoracic Oncology, 4(9):suppl. 1, abst M39.2, S164 (IASLC 13th World Conf of Lung Cancer, oral presentation);
- Year
- 2009
- Research Committee(s)
- Lung
- Study Number(s)
- S0424
Biomarkers of polycyclic aromatic hydrocarbon-DNA damage and cigarette smoke exposure
- Journal / Conference
- Journal of Thoracic Oncology 4(9):suppl 1, abst. M38.5, S163 (oral pres., IASLC 13th World Conf of Lung Cancer)
- Year
- 2009
- Research Committee(s)
- Lung
- Study Number(s)
- S0424
Molecular epidemiology of lung cancer
- Journal / Conference
- Journal of Thoracic Oncology 4(9):suppl 1, abst. M39.3, S164 (oral presentation, 13th World Conference of Lung Cancer)
- Year
- 2009
- Research Committee(s)
- Lung
- Study Number(s)
- S0424
Role of EGFR pathway activation in never smoking patients with lung cancer
- Journal / Conference
- Journal of Thoracic Oncology 4(9):suppl 1, abst. #PD3.5.5, S455; IASLC 13th World Conf on Lung Cancer, oral;
- Year
- 2009
- Research Committee(s)
- Lung
- Study Number(s)
- S0536
S0536: Carboplatin, paclitaxel, cetuximab and bevacizumab followed by cetuximab and bevacizumab maintenance in advanced non-small cell lung cancer (NSCLC), a SWOG phase II study
- Journal / Conference
- Journal of Thoracic Oncology 4(9):suppl. 1, Abst. #E9.3, S201; 2009 (IASLC 13th World Conf on Lung Cancer, oral;
- Year
- 2009
- Research Committee(s)
- Lung
- Study Number(s)
- S9900